methamphetamine has been researched along with quinoxalines in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Clineschmidt, BV; Haubrich, D; Lotti, VJ; Porter, CC | 1 |
| Engelhardt, EL; Hartman, RD; Lotti, VJ; Lumma, WC; Saari, WS; Stone, CA | 1 |
| Witkin, JM | 1 |
| Akiyama, K; Kodama, M; Kuroda, S; Sakai, K; Shimizu, Y; Ujike, H | 1 |
| Glick, SD; Maisonneuve, IM; Shoblock, JR; Sullivan, EB | 1 |
| Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jordà, EG; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E | 1 |
| Hattori, K; Ishida, J; Iwashita, A; Matsuoka, N; Matsuura, S; Mihara, K; Mutoh, S; Yamamoto, H; Yamazaki, S | 1 |
| Bonhomme, N; Goldstein, S; Lestage, P; Lockhart, B; Roger, A | 1 |
| Miyatake, M; Nakamura, A; Narita, M; Shibasaki, M; Suzuki, T | 1 |
| Lyon, GJ | 1 |
| Bergman, J; Desai, RI | 1 |
| Bennett, RS; De La Garza, R; Mahoney, JJ; Newton, TF; Thompson-Lake, DG; Verrico, CD | 1 |
| De La Garza, R; Kalechstein, AD; Mahoney, JJ; Verrico, CD | 1 |
| Chang, CH; Gean, PW; Huang, CH; Yu, YJ | 1 |
| Amchova, P; Ruda-Kucerova, J; Siska, F; Tizabi, Y | 1 |
2 trial(s) available for methamphetamine and quinoxalines
| Article | Year |
|---|---|
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Methamphetamine; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline; Young Adult | 2014 |
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.
Topics: Acoustic Stimulation; Adult; Amphetamine-Related Disorders; Auditory Perception; Benzazepines; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; Nicotinic Agonists; Nootropic Agents; Photic Stimulation; Quinoxalines; Reaction Time; Time Factors; Treatment Outcome; Varenicline; Visual Perception | 2014 |
13 other study(ies) available for methamphetamine and quinoxalines
| Article | Year |
|---|---|
6-Chloro-2(1-piperazinyl) quinoxaline (CPQ): action on serotonin-induced behavioral responses and interactions with chloromethamphetamine and dimethyl-meta-tyramine.
Topics: Animals; Behavior, Animal; Brain Chemistry; Drug Interactions; Female; Male; Methamphetamine; Motor Activity; Myocardium; Neurons; Quinoxalines; Rats; Serotonin; Serotonin Antagonists; Tyramine | 1978 |
Piperazinylquinoxalines with central serotoninmimetic activity.
Topics: Animals; Chemical Phenomena; Chemistry; Male; Methamphetamine; Neurons; Piperazines; Quinoxalines; Rats; Serotonin | 1981 |
Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists.
Topics: Amino Acids; Animals; Cocaine; Excitatory Amino Acid Antagonists; Glutamic Acid; Kynurenic Acid; Male; Methamphetamine; Mice; Motor Activity; Pyrrolidinones; Quinoxalines | 1993 |
Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocaine-induced behavioral sensitization.
Topics: Animals; Cocaine; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Male; Methamphetamine; Premedication; Quinoxalines; Rats; Rats, Sprague-Dawley; Stereotypic Movement Disorder | 1998 |
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors; Valine | 2003 |
Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
Topics: alpha-Tocopherol; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspases; Cerebellum; Cytochromes c; Dizocilpine Maleate; Drug Interactions; Enzyme Activation; Flow Cytometry; Methamphetamine; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Reactive Oxygen Species | 2004 |
A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
Topics: Animals; Benzamides; Body Temperature; Brain; Corpus Striatum; Dopamine; Enzyme Inhibitors; Lipid Peroxidation; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; PC12 Cells; Poly(ADP-ribose) Polymerase Inhibitors; Quinoxalines; Rats; Substantia Nigra | 2004 |
In vivo neuroprotective effects of the novel imidazolyl nitrone free-radical scavenger (Z)-alpha-[2-thiazol-2-yl)imidazol-4-yl]-N-tert-butylnitrone (S34176).
Topics: Animals; Brain Ischemia; Cell Survival; Corpus Striatum; Dopamine; Free Radical Scavengers; Hippocampus; Imidazoles; Kainic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Nitrogen Oxides; Quinoxalines; Rats; Rats, Wistar | 2005 |
Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence.
Topics: Amphetamine-Related Disorders; Animals; Astrocytes; Calcium; Cell Communication; Central Nervous System Stimulants; Coculture Techniques; Conditioning, Operant; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microscopy, Confocal; Neuroglia; Neurons; Piperidines; Pregnancy; Protein Kinase C; Pyridines; Quinoxalines; Receptors, Glutamate; Synaptic Transmission | 2005 |
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Topics: Adult; Amphetamine-Related Disorders; Benzazepines; Borderline Personality Disorder; Depressive Disorder, Major; Drug Partial Agonism; Female; Humans; Irritable Mood; Methamphetamine; Nicotinic Agonists; Paranoid Disorders; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2008 |
Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.
Topics: Animals; Behavior, Animal; Benzazepines; Cholinergic Agents; Cholinesterase Inhibitors; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Methamphetamine; Muscarinic Antagonists; Nicotinic Agonists; Nicotinic Antagonists; Pentobarbital; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Varenicline | 2010 |
Involvement of protein phosphatases in the destabilization of methamphetamine-associated contextual memory.
Topics: Amygdala; Animals; Anisomycin; Calcium Signaling; Conditioning, Classical; Dendritic Spines; Dizocilpine Maleate; Male; Memory Consolidation; Mental Recall; Methamphetamine; Mice, Inbred C57BL; Phosphoprotein Phosphatases; Protein Synthesis Inhibitors; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2016 |
NBQX attenuates relapse of nicotine seeking but not nicotine and methamphetamine self-administration in rats.
Topics: Animals; Dose-Response Relationship, Drug; Male; Methamphetamine; Nicotine; Quinoxalines; Rats; Rats, Wistar; Recurrence; Self Administration | 2021 |